Evaluating the Evidence behind Policy Mandates in US Dialysis Care
Author(s) -
Kevin F. Erickson,
Wolfgang C. Winkelmayer
Publication year - 2018
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2018090905
Subject(s) - medicaid , reimbursement , dialysis , medicine , context (archaeology) , capitation , intensive care medicine , payment , business , family medicine , health care , finance , economic growth , economics , paleontology , biology
Approximately 25% of patients initiating dialysis in the United States are covered by state Medicaid programs, and Medicare covers 65% of all prevalent patients receiving dialysis, presenting significant challenges for federal and state budgets.[1][1] In an effort to contain costs without
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom